NCT05511311

Brief Summary

There is an increasing number of elderly population, not only in Indonesia, but also in the world. With increasing of age, there is also an increasing number of elderly with sarcopenia and frailty. Both of the diseases can lead to dependency, decrease quality of life, and morbidity. Besides nutrition, physical activity, especially resistance training is proven to be beneficial in improving sarcopenia and frailty condition. Currently in Cipto Mangunkusumo National Hospital (RSCM), there is no comprehensive frailty prevention clinic in the geriatric inpatient clinics. This research can be the base of frailty and sarcopenia treatment in RSCM.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
220

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 17, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 22, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2022

Completed
Last Updated

August 22, 2022

Status Verified

August 1, 2022

Enrollment Period

10 months

First QC Date

August 17, 2022

Last Update Submit

August 19, 2022

Conditions

Keywords

frailtysarcopeniaelderlyresistance training

Outcome Measures

Primary Outcomes (4)

  • Frailty Status

    The FRAIL scale includes 5 components: Fatigue, Resistance, Ambulation, Illness, and Loss of weight (10). Frail scale scores range from 0-5 (i.e., 1 point for each component; 0=best to 5=worst) and represent frail (3-5), pre-frail (1-2), and robust (0) health status

    12 weeks

  • Sarcopenia Status

    Measured using: * BIA: \<7.0 kg/m2 in men and \<5.7 kg/m2 in women * Five times sit to stand: ≥12 seconds * Hand-grip strength: \<28 kg for men and \<18 kg for women

    12 weeks

  • Walking Speed

    \<1.0 m/s

    12 weeks

  • Patient's Quality of Life

    Measured by EQ-5D: ranging from 0 ('worst imaginable health') to 100 ('best imaginable health')

    12 weeks

Secondary Outcomes (2)

  • Prevalence of Frailty

    12 weeks

  • Prevalence of Sarcopenia

    12 weeks

Study Arms (2)

Control

ACTIVE COMPARATOR

12-week of Standard Therapy using elastic-band

Procedure: Standard Therapy

Intervention

EXPERIMENTAL

12-week of Resistance Training developed by RSCM using sand-bag

Procedure: Resistance Training

Interventions

Resistance training developed by the researcher (SCR-RSCM) for 12 weeks

Intervention

Standard therapy for 12 weeks

Control

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients 60 years old or orlder
  • Categorized as Pre-frail or Frail based on FRAIL criteria
  • Is not in routine physical activity in the past 3 months
  • Succeeded Mini Physical Performance Test with score 11 or more

You may not qualify if:

  • Cognitive Disturbance (Abbreviated Mental Test \< 8)
  • Not consenting to join the trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cipto Mangunkusumo National Hospital

Jakarta, Jakarta Pusat, 10310, Indonesia

RECRUITING

Related Publications (3)

  • Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, Kojima T, Kuzuya M, Lee JSW, Lee SY, Lee WJ, Lee Y, Liang CK, Lim JY, Lim WS, Peng LN, Sugimoto K, Tanaka T, Won CW, Yamada M, Zhang T, Akishita M, Arai H. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2. doi: 10.1016/j.jamda.2019.12.012. Epub 2020 Feb 4.

  • Mienche M, Setiati S, Setyohadi B, Kurniawan J, Laksmi PW, Ariane A, Tirtarahardja G. Diagnostic Performance of Calf Circumference, Thigh Circumference, and SARC-F Questionnaire to Identify Sarcopenia in Elderly Compared to Asian Working Group for Sarcopenia's Diagnostic Standard. Acta Med Indones. 2019 Apr;51(2):117-127.

  • Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169.

MeSH Terms

Conditions

FrailtySarcopenia

Interventions

Resistance TrainingStandard of Care

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalSigns and Symptoms

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaQuality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof

Study Record Dates

First Submitted

August 17, 2022

First Posted

August 22, 2022

Study Start

January 1, 2022

Primary Completion

October 31, 2022

Study Completion

November 30, 2022

Last Updated

August 22, 2022

Record last verified: 2022-08

Locations